Skip to main content
Erschienen in: Documenta Ophthalmologica 3/2024

17.04.2024 | Clinical Case Report

Clinical course of two siblings with potassium voltage-gated channel modifier subfamily V member 2 (KCNV2)-associated retinopathy

verfasst von: Tomoko Sato, Kazuki Kuniyoshi, Takaaki Hayashi, Hirokazu Nishiwaki, Kei Mizobuchi, Shunji Kusaka

Erschienen in: Documenta Ophthalmologica | Ausgabe 3/2024

Einloggen, um Zugang zu erhalten

Abstract

Background

KCNV2-associated retinopathy causes a phenotype reported as “cone dystrophy with nyctalopia and supernormal rod responses (CDSRR; OMIM# 610356),” featuring pathognomonic findings on electroretinography (ERG). Here, we report the clinical courses of two siblings with CDSRR.

Case reports

Patient 1: A 3-year-old boy with intermittent exophoria was referred to our hospital. The patient’s decimal best-corrected visual acuity (BCVA) at age 6 was 0.7 and 0.7 in the right and left eyes, respectively. Photophobia and night blindness were also observed. Because the ERG showed a delayed and supernormal b-wave with a “squaring (trough-flattened)” a-wave in the DA-30 ERG, and CDSRR was diagnosed. The patient’s vision gradually worsened, and faint bilateral bull’s eye maculopathy was observed at the age of 27 years, although the fundi were initially unremarkable. Genetic examination revealed a homozygous missense variant, c.529T > C (p.Cys177Arg), in the KCNV2 gene.
Patient 2: The second patient was Patient 1’s younger sister, who was brought to our hospital at 3 years of age. The patient presented with exotropia, mild nystagmus, photophobia, night blindness, and color vision abnormalities. The patients’ decimal BCVA at age 13 was 0.6 and 0.4 in the right and left eyes, respectively, and BCVA gradually decreased until the age of 24 years. The fundi were unremarkable. The siblings had similar ERG findings and the same homozygous missense variant in the KCNV2 gene.

Conclusions

The siblings had clinical findings typical of CDSRR. High-intense flash ERG is recommended for identifying pathognomonic “squaring” a-waves in patients with CDSRR.
Literatur
1.
Zurück zum Zitat Gouras P, Eggers HM, MacKay CJ (1983) Cone dystrophy, nyctalopia, and supernormal rod responses. A new retinal degeneration. Arch Ophthalmol 101:718–724CrossRefPubMed Gouras P, Eggers HM, MacKay CJ (1983) Cone dystrophy, nyctalopia, and supernormal rod responses. A new retinal degeneration. Arch Ophthalmol 101:718–724CrossRefPubMed
2.
Zurück zum Zitat Rosenberg T, Simonsen SE (1993) Retinal cone dysfunction of supernormal rod ERG type. Five new cases. Acta Ophthalmol (Copenh) 71:246–255CrossRefPubMed Rosenberg T, Simonsen SE (1993) Retinal cone dysfunction of supernormal rod ERG type. Five new cases. Acta Ophthalmol (Copenh) 71:246–255CrossRefPubMed
3.
Zurück zum Zitat Michaelides M, Holder GE, Webster AR, Hunt DM, Bird AC, Fitzke FW et al (2005) A detailed phenotypic study of “cone dystrophy with supernormal rod ERG”. Br J Ophthalmol 89:332–339CrossRefPubMedPubMedCentral Michaelides M, Holder GE, Webster AR, Hunt DM, Bird AC, Fitzke FW et al (2005) A detailed phenotypic study of “cone dystrophy with supernormal rod ERG”. Br J Ophthalmol 89:332–339CrossRefPubMedPubMedCentral
4.
Zurück zum Zitat Georgiou M, Robson AG, Fujinami K, Leo SM, Vincent A, Nasser F et al (2020) KCNV2-associated retinopathy: genetics, electrophysiology, and clinical course-KCNV2 Study Group Report 1. Am J Ophthalmol 225:95–107CrossRefPubMed Georgiou M, Robson AG, Fujinami K, Leo SM, Vincent A, Nasser F et al (2020) KCNV2-associated retinopathy: genetics, electrophysiology, and clinical course-KCNV2 Study Group Report 1. Am J Ophthalmol 225:95–107CrossRefPubMed
5.
Zurück zum Zitat Georgiou M, Fujinami K, Vincent A, Nasser F, Khateb S, Vargas ME et al (2021) KCNV2-associated retinopathy: detailed retinal phenotype and structural endpoints-KCNV2 Study Group Report 2. Am J Ophthalmol 230:1–11CrossRefPubMedPubMedCentral Georgiou M, Fujinami K, Vincent A, Nasser F, Khateb S, Vargas ME et al (2021) KCNV2-associated retinopathy: detailed retinal phenotype and structural endpoints-KCNV2 Study Group Report 2. Am J Ophthalmol 230:1–11CrossRefPubMedPubMedCentral
6.
Zurück zum Zitat Hood DC, Cideciyan AV, Halevy DA, Jacobson SG (1996) Sites of disease action in a retinal dystrophy with supernormal and delayed rod electroretinogram b-waves. Vision Res 36:889–901CrossRefPubMed Hood DC, Cideciyan AV, Halevy DA, Jacobson SG (1996) Sites of disease action in a retinal dystrophy with supernormal and delayed rod electroretinogram b-waves. Vision Res 36:889–901CrossRefPubMed
7.
Zurück zum Zitat Fujinami K, Tsunoda K, Nakamura N, Kato Y, Noda T, Shinoda K et al (2013) Molecular characteristics of four Japanese cases with KCNV2 retinopathy: report of novel disease-causing variants. Mol Vis 19:1580–1590PubMedPubMedCentral Fujinami K, Tsunoda K, Nakamura N, Kato Y, Noda T, Shinoda K et al (2013) Molecular characteristics of four Japanese cases with KCNV2 retinopathy: report of novel disease-causing variants. Mol Vis 19:1580–1590PubMedPubMedCentral
8.
Zurück zum Zitat Wu H, Cowing JA, Michaelides M, Wilkie SE, Jeffery G, Jenkins SA et al (2006) Mutations in the gene KCNV2 encoding a voltage-gated potassium channel subunit cause “cone dystrophy with supernormal rod electroretinogram” in humans. Am J Hum Genet 79:574–579CrossRefPubMedPubMedCentral Wu H, Cowing JA, Michaelides M, Wilkie SE, Jeffery G, Jenkins SA et al (2006) Mutations in the gene KCNV2 encoding a voltage-gated potassium channel subunit cause “cone dystrophy with supernormal rod electroretinogram” in humans. Am J Hum Genet 79:574–579CrossRefPubMedPubMedCentral
9.
Zurück zum Zitat Robson AG, Frishman LJ, Grigg J, Hamilton R, Jeffrey BG, Kondo M et al (2022) ISCEV Standard for full-field clinical electroretinography (2022 update). Doc Ophthalmol 144:165–177CrossRefPubMedPubMedCentral Robson AG, Frishman LJ, Grigg J, Hamilton R, Jeffrey BG, Kondo M et al (2022) ISCEV Standard for full-field clinical electroretinography (2022 update). Doc Ophthalmol 144:165–177CrossRefPubMedPubMedCentral
10.
Zurück zum Zitat Johnson MA, Jeffrey BG, Messias AMV, Robson AG (2019) ISCEV extended protocol for the stimulus-response series for the dark-adapted full-field ERG b-wave. Doc Ophthalmol 138:217–227CrossRefPubMed Johnson MA, Jeffrey BG, Messias AMV, Robson AG (2019) ISCEV extended protocol for the stimulus-response series for the dark-adapted full-field ERG b-wave. Doc Ophthalmol 138:217–227CrossRefPubMed
11.
Zurück zum Zitat Hayashi T, Mizobuchi K, Kikuchi S, Nakano T (2021) Novel biallelic TRPM1 variants in an elderly patient with complete congenital stationary night blindness. Doc Ophthalmol 142:265–273CrossRefPubMed Hayashi T, Mizobuchi K, Kikuchi S, Nakano T (2021) Novel biallelic TRPM1 variants in an elderly patient with complete congenital stationary night blindness. Doc Ophthalmol 142:265–273CrossRefPubMed
12.
Zurück zum Zitat Mizobuchi K, Hayashi T, Matsuura T, Nakano T (2022) Clinical characterization of autosomal dominant retinitis pigmentosa with NRL mutation in a three-generation Japanese family. Doc Ophthalmol 144:227–235CrossRefPubMed Mizobuchi K, Hayashi T, Matsuura T, Nakano T (2022) Clinical characterization of autosomal dominant retinitis pigmentosa with NRL mutation in a three-generation Japanese family. Doc Ophthalmol 144:227–235CrossRefPubMed
13.
Zurück zum Zitat Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J et al (2015) Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med 17:405–424CrossRefPubMedPubMedCentral Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J et al (2015) Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med 17:405–424CrossRefPubMedPubMedCentral
14.
Zurück zum Zitat Abdelkader E, Yasir ZH, Khan AM, Raddadi O, Khandekar R, Alateeq N et al (2020) Analysis of retinal structure and function in cone dystrophy with supernormal rod response. Doc Ophthalmol 141:23–32CrossRefPubMed Abdelkader E, Yasir ZH, Khan AM, Raddadi O, Khandekar R, Alateeq N et al (2020) Analysis of retinal structure and function in cone dystrophy with supernormal rod response. Doc Ophthalmol 141:23–32CrossRefPubMed
15.
Zurück zum Zitat Wissinger B, Dangel S, Jägle H, Hansen L, Baumann B, Rudolph G et al (2008) Cone dystrophy with supernormal rod response is strictly associated with mutations in KCNV2. Invest Ophthalmol Vis Sci 49:751–757CrossRefPubMed Wissinger B, Dangel S, Jägle H, Hansen L, Baumann B, Rudolph G et al (2008) Cone dystrophy with supernormal rod response is strictly associated with mutations in KCNV2. Invest Ophthalmol Vis Sci 49:751–757CrossRefPubMed
16.
Zurück zum Zitat Friedburg C, Wissinger B, Schambeck M, Bonin M, Kohl S, Lorenz B (2011) Long-term follow-up of the human phenotype in three siblings with cone dystrophy associated with a homozygous p. G461R mutation of KCNV2. Invest Ophthalmol Vis Sci 52:8621–8629CrossRefPubMed Friedburg C, Wissinger B, Schambeck M, Bonin M, Kohl S, Lorenz B (2011) Long-term follow-up of the human phenotype in three siblings with cone dystrophy associated with a homozygous p. G461R mutation of KCNV2. Invest Ophthalmol Vis Sci 52:8621–8629CrossRefPubMed
17.
Zurück zum Zitat Nakamura N, Tsunoda K, Fujinami K, Shinoda K, Tomita K, Hatase T et al (2013) Long-term observation over ten years of four cases of cone dystrophy with supernormal rod electroretinogram. Nippon Ganka Gakkai Zasshi (J Jpn Ophthalmol Soc) 117:629–640 Nakamura N, Tsunoda K, Fujinami K, Shinoda K, Tomita K, Hatase T et al (2013) Long-term observation over ten years of four cases of cone dystrophy with supernormal rod electroretinogram. Nippon Ganka Gakkai Zasshi (J Jpn Ophthalmol Soc) 117:629–640
18.
Zurück zum Zitat Lie H, Wang G, Liu X, Meng X, Long Y, Ren J et al (2021) Long-term follow-up of a Chinese patient with KCNV2-retinopathy. Ophthalmic Genet 42:144–149CrossRefPubMed Lie H, Wang G, Liu X, Meng X, Long Y, Ren J et al (2021) Long-term follow-up of a Chinese patient with KCNV2-retinopathy. Ophthalmic Genet 42:144–149CrossRefPubMed
19.
Zurück zum Zitat Czirják G, Tóth ZE, Enyedi P (2007) Characterization of the heteromeric potassium channel formed by Kv2.1 and the retinal subunit Kv8.2 in Xenopus Oocytes. J Neurophysiol 98:1213–1222CrossRefPubMed Czirják G, Tóth ZE, Enyedi P (2007) Characterization of the heteromeric potassium channel formed by Kv2.1 and the retinal subunit Kv8.2 in Xenopus Oocytes. J Neurophysiol 98:1213–1222CrossRefPubMed
20.
Zurück zum Zitat Winkler BS (1973) Dependence of fast components of the electroretinogram of the isolated rat retina on the ionic environment. Vision Res 13:457–463CrossRefPubMed Winkler BS (1973) Dependence of fast components of the electroretinogram of the isolated rat retina on the ionic environment. Vision Res 13:457–463CrossRefPubMed
21.
Zurück zum Zitat Hart NS, Mountford JK, Voigt V, Fuller-Carter P, Barth M, Nerbonne JM et al (2019) The role of the voltage-gated potassium channel proteins Kv8.2 and Kv2.1 in vision and retinal disease: insights from the study of mouse gene knock-out mutations. eNeuro. 6:e0032-19CrossRef Hart NS, Mountford JK, Voigt V, Fuller-Carter P, Barth M, Nerbonne JM et al (2019) The role of the voltage-gated potassium channel proteins Kv8.2 and Kv2.1 in vision and retinal disease: insights from the study of mouse gene knock-out mutations. eNeuro. 6:e0032-19CrossRef
22.
Zurück zum Zitat Jiang X, Rashwan R, Voigt V, Nerbonne J, Hunt DM, Carvalho LS (2021) Molecular, cellular and functional changes in the retinas of young adult mice lacking the voltage-gated K+ channel subunits Kv8.2 and K2.1. Int J Mol Sci 22:4877CrossRefPubMedPubMedCentral Jiang X, Rashwan R, Voigt V, Nerbonne J, Hunt DM, Carvalho LS (2021) Molecular, cellular and functional changes in the retinas of young adult mice lacking the voltage-gated K+ channel subunits Kv8.2 and K2.1. Int J Mol Sci 22:4877CrossRefPubMedPubMedCentral
23.
Zurück zum Zitat Sudharsan R, Simone KM, Anderson NP, Aguirre GD, Beltran WA (2017) Acute and protracted cell death in light-induced retinal degeneration in the canine model of rhodopsin autosomal dominant retinitis pigmentosa. Invest Ophthalmol Vis Sci 58:270–281CrossRefPubMedPubMedCentral Sudharsan R, Simone KM, Anderson NP, Aguirre GD, Beltran WA (2017) Acute and protracted cell death in light-induced retinal degeneration in the canine model of rhodopsin autosomal dominant retinitis pigmentosa. Invest Ophthalmol Vis Sci 58:270–281CrossRefPubMedPubMedCentral
24.
Zurück zum Zitat Kaizuka C, Hayashi T, Mizobuchi K, Kubota M, Ueno S, Nakano T (2021) Transient electroretinographic abnormalities that mimic those of KCNV2 retinopathy: a case report. Doc Ophthalmol 143:221–228CrossRefPubMedPubMedCentral Kaizuka C, Hayashi T, Mizobuchi K, Kubota M, Ueno S, Nakano T (2021) Transient electroretinographic abnormalities that mimic those of KCNV2 retinopathy: a case report. Doc Ophthalmol 143:221–228CrossRefPubMedPubMedCentral
25.
Zurück zum Zitat Nagae Y, Kuniyoshi K, Ishibashi M, Tanabe F, Matsumoto C, Kusaka S (2023) Fundus autofluorescence, optical coherence tomography and electroretinography abnormalities in a patient with digoxin retinopathy that resemble those in KCNV2-associated retinopathy. Doc Ophthalmol 147:131–137CrossRefPubMed Nagae Y, Kuniyoshi K, Ishibashi M, Tanabe F, Matsumoto C, Kusaka S (2023) Fundus autofluorescence, optical coherence tomography and electroretinography abnormalities in a patient with digoxin retinopathy that resemble those in KCNV2-associated retinopathy. Doc Ophthalmol 147:131–137CrossRefPubMed
Metadaten
Titel
Clinical course of two siblings with potassium voltage-gated channel modifier subfamily V member 2 (KCNV2)-associated retinopathy
verfasst von
Tomoko Sato
Kazuki Kuniyoshi
Takaaki Hayashi
Hirokazu Nishiwaki
Kei Mizobuchi
Shunji Kusaka
Publikationsdatum
17.04.2024
Verlag
Springer Berlin Heidelberg
Erschienen in
Documenta Ophthalmologica / Ausgabe 3/2024
Print ISSN: 0012-4486
Elektronische ISSN: 1573-2622
DOI
https://doi.org/10.1007/s10633-024-09971-0

Weitere Artikel der Ausgabe 3/2024

Documenta Ophthalmologica 3/2024 Zur Ausgabe

Neu im Fachgebiet Augenheilkunde

Metastase in der periokulären Region

Metastasen Leitthema

Orbitale und periokuläre metastatische Tumoren galten früher als sehr selten. Aber mit der ständigen Aktualisierung von Medikamenten und Nachweismethoden für die Krebsbehandlung werden neue Chemotherapien und Strahlenbehandlungen eingesetzt. Die …

Staging und Systemtherapie bei okulären und periokulären Metastasen

Metastasen Leitthema

Metastasen bösartiger Erkrankungen sind die häufigsten Tumoren, die im Auge diagnostiziert werden. Sie treten bei ungefähr 5–10 % der Patienten mit soliden Tumoren im Verlauf der Erkrankung auf. Besonders häufig sind diese beim Mammakarzinom und …

Wundheilung nach Trabekulektomie

Trabekulektomie CME-Artikel

Die überschießende Wundheilung in der filtrierenden Glaukomchirurgie ist ein zentraler Faktor für ein operatives Versagen. Nach der Einführung der Trabekulektomie in den 1960er-Jahren wurden viele Faktoren erkannt, die mit einer vermehrten …

„standard operating procedures“ (SOP) – Vorschlag zum therapeutischen Management bei periokulären sowie intraokulären Metastasen

Metastasen Leitthema

Peri- sowie intraokuläre Metastasen sind insgesamt gesehen selten und meist Zeichen einer fortgeschrittenen primären Tumorerkrankung. Die Therapie ist daher zumeist palliativ und selten kurativ. Zudem ist die Therapiefindung sehr individuell. Die …

Update Augenheilkunde

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.